Melanoma Trial, Recruiting (NCT01205815)

Melanoma Trial, Recruiting NCT01205815 Sponsor: Vanderbilt-Ingram Cancer Center Condition: Melanoma

Printed from Voxsanity (voxsanity.com.au) — NCT01205815 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Melanoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with melanoma (a type of skin cancer), confirmed through a lab test or tissue sample
You are scheduled to have a test or procedure that may produce leftover tissue that could be stored for future research, OR you have already had such a procedure but have not yet been asked to take part in this study

Who may not be able to join:

You have a serious health condition that makes it unsafe to have blood drawn (such as severe anemia) — however, if you are willing to provide a stored tissue sample (a wax-embedded block or 10–15 prepared slides from your diagnosis), this may not apply to you (confirm with trial site)
You are unable or unwilling to give your consent to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Douglas Johnson, M.D., Vanderbilt-Ingram Cancer Center

Phone: 800-811-8480

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT01205815

Sponsor: Vanderbilt-Ingram Cancer Center

Phase: Not Applicable

Status: Recruiting

Condition: Melanoma

Trial contact: 800-811-8480

More information: https://clinicaltrials.gov/study/NCT01205815

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with melanoma (a type of skin cancer), confirmed through a lab test or tissue sample
You are scheduled to have a test or procedure that may produce leftover tissue that could be stored for future research, OR you have already had such a procedure but have not yet been asked to take part in this study

Who may not be able to join:

You have a serious health condition that makes it unsafe to have blood drawn (such as severe anemia) — however, if you are willing to provide a stored tissue sample (a wax-embedded block or 10–15 prepared slides from your diagnosis), this may not apply to you (confirm with trial site)
You are unable or unwilling to give your consent to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Vanderbilt-Ingram Cancer Center

Registry

ClinicalTrials.gov

Start date

3 June 2010

Est. completion

1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Molecular changes in patients' melanoma tissue

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov